Hernández R, Fernández MA, Miranda G, Suástegui R

Language: Spanish
References: 51
Page: 522-531
PDF size: 424.29 Kb.

ABSTRACT

Introduction. Phenytoin and carbamazepine were the antiepileptic drugs most frequently used in Mexico and throughout the world. Epileptic patients who take these drugs have a variety of collateral effects including the decrease of folates plasmatic level. Low seric folic acid concentration has been associated with a decline in cognitive functions. The administration of a combined treatment with folic acid could ameliorate these difficulties. Objective. To describe the effect of the folic acid in the cognitive function in epileptic patients who take phenytoin and carbamazepine. Methods. We chose patient who have epilepsy and that are being treated with phenytoin, carbamazepine or both and formed two groups. The study group was treated with a daily dose of 5 mg of folic acid and the control group was administered placebo for a period of six months, with nine patients in each group of same age, sex, education level, epilepsy’s evolution, frequency of seizures, EEG abnormalities and antiepileptic drugs plasma levels. We registered data at the beginning (basal) and at the end of the study. Results. Measurements of basal folic acid plasma levels in both groups were under the referential value. The neuropsychological assessment at the beginning (Mini-Barcelona test) showed a deficit in the verbal memory skills in both groups. After six months of treatment with folic acid (study group), the folic acid plasma level was 12.2 mg/mL (p ‹ 0.01) higher than the basal value. Verbal memory test has improved with respect to the basal value (p ‹ 0.05). The numbers of seizures and the plasma levels of the antiepileptic drugs remained unchanged. On the other hand, the group treated with placebo did not improve. Conclusion. Treatment with folic acid is safe and without side effects, it improved the cognitive function in patients with epilepsy treated with phenytoin and carbamazepine.

REFERENCES

1. Blum D, Bortz J. Neurobehavioral aspects of epilepsy. Curr Op Psych 1998; 11: 321-6.

2. Dodrill CB. Neuropsychological aspects of epilepsy. Psych Clin North Am 1992; 15: 384-94.

3. Rausch R. Neuropsychological and psychosocial follow up of patients with temporal lobectomy surgery for intractable epilepsy: result at 1 year an 10 years. Epilepsia 1995; 36(Suppl. 1) 4: S 318.

4. Kilpatrick C, Murrie V, Cook M, Andrews D. Degree of left hippocampal atrophy correlates with severity of neuropsychological deficits. Seizure 1997; 6: 213-18.

5. Krauss GL, Summerfield M, Brandt J, Breiter S. Mesial temporal spikes interfere with working memory. Neurology 1997; 49: 975-80.

6. Helmstaedter C, Elger C, Lendt M. Postictal courses of cognitive deficits in focal epilepsies. Epilepsia 1994; 35: 1073-8.

7. Tisher PW, Holzer JC, Greenberg M, Benjamin S. Psychiatric presentations of epilepsy. Harv Rev Psychiatry 1993; 1: 219-28.

8. Devinsky O, Gerhengorn J, Brown E, Perrine K. Frontal functions in juvenile myoclonic epilepsy. Neuropsy Neuropsych, Behav Neurol 1997; 10: 243-6.

9. Helmstaeder C, Kemper B, Elger C. Neuropsychological aspects of frontal lobe epilepsy. Neuropsych 1996; 34: 399-406.

10. Prevey M, Delaney R, Cramer J, Catanach L, Effect of valproate on cognitive functioning. Comparison with carbamazepine. Arch Neurol 1996; 53: 1008-16.

11. Schmitz. Psychiatric syndromes related to antiepiletics drugs. Epilepsia 1999; 40: S65- S70.

12. Reynolds EH, Trimble MR. Adverse neuropsychiatric effects of anticonvulsivants drugs. Drugs 1985; 29: 570-81.

13. Gigli GL, Maschio M, Diomedi M, Placidi F. Cognitive performances in newly referred patients with temporal lobe epilepsy: comparison with normal subjects in basal condition and after treatment with controlled-release carbamazepine. Int J Neusrosci 1996; 88: 97-107.

14. Reynolds E, Travers R. Serum anticonvulsivant concentrations in epileptic patients with mental symptoms. Br J Psychiat 1974; 124: 440-5.

15. Froscher W, Maier V, Laage M, Wolfersdorf M. Folates deficiency, anticonvulsivant drugs, and psychiatric morbidity. Clin Neuropharmacol 1995; 18: 165-82.

16. Gogging T, Gough H, Bisseassar A, Crowley M, Baker M. A comparative study of the relative effects of anticonvulsivant drugs and dietary folate on the red cell folates status of patients with epilepsy. Q J Med 1987; 65: 911-14.

17. Deb S. Effects of folate metabolism on the psychopathology of adults with mental retardation and epilepsy. Am J Ment Retard 1994; 98: 717-23.

18. Berg M, Fincham R, Ebert E, Schottelius D. Decrease of serum folates in healthy male volunteers taking phenytoin. Epilepsia 1988; 29: 67-73.

19. Botez M, Ypung S. Effects of anticonvulsivants treatment and low levels of folate and thiamine on amine metabolites in cerebrospinal fluid. Brain 1991; 114: 333-48.

20. Lewis DP, Van Dyke DC, Willhite LA, Stumbo PJ, Berg MJ. Phenytoi-folic acid interaction. Ann Pharmacoth 1995; 29: 726-35.

21. Hendel J, Mogens D, Lenart G, Winkel P. The effects of carabamazepine and valproate on folate metabolism in man. Acta Neurol Scand 1984; 69: 226-31.

22. Kishi T, Fujita N, Euguchi T, Ueda K. Mechanism for reduction of serum folate by antiepileptics drugs during prolonged therapy. J Neurol Sci 1997; 145: 109-12.

23. Hassing L, Wahlin A, Winbland B, Backman L. Further evidence on the effects of vitamin B12 and folate levels episodic memory functioning: a population-based study of health very old adults. Biol Psychiatrya 1999; 45: 1472-80.

24. Skerrit UM. A prevalence study of folate deficiency in a psychiatric in patient population. Act Psychiat Scan 1998; 97: 228-32.

25. Hutto BR. Folate and cobalamine in psychiatric illness. Compare Psychiatry 1997; 38: 305-14.

26. Muller WH, Froscher W. Neurologic and psychologic disorders in folic acid deficiency. Fortschr Neurol Psychiatr 1989; 57: 395-401.

27. Edeh J, Toone K. Antiepileptic therapy, folate deficiency, and psychiatric morbidity: A general practice survey. Epilepsia 1985; 26: 434-40.

28. Campbell N. How safe are folic acid supplements. Arch Inter Med 1996; 156: 1638-44.

29. Chien L, Krumdieck C, Scott C, Butterworth Harmful effect of megadose of vitamins: electroenchephalogram abnormalities and seiuzure induced for intravenous folate in drug-treated epileptics. Am J Clin Nutr 1975; 28: 51-8.

30. Seligmann H, Potasman I, Weller B, Schwartz M. Phenytoin-folic interaction: A lesson to be learned. Clin Neuropharm 1999; 22: 268-72.

31. Baylis EM, Crowley JM, Preece JM, Sylvester PE, Marks V. Influence of folic acid on blood-phenytoin levels. Lancet 1971; 1: 62-4.

32. Norris JW, Pratt RF, A controlled study of folic acid in epilepsy. Neurology 1971; 21: 659-64.

33. Bergins PS, Thompson PJ, Fish DR, Shorvon SD. The effect of seizure in memory for recently learned material. Neurology 1995; 45: 236-40.

34. Peña-Casanova, Guardia J, Bertrán-Serra, Maner R, Jarne A. Versión abreviada del Tes. Barcelona (I) subtest y perfiles normales. Neurología 1997; 12: 9-23.

35. Guardia J, Peña-Casanova J, Bertrán-Serra I, Manero R, Meza M. Versión abreviada del Tes. Barcelona (II) puntación global normalizada. Neurología 1997; 12: 24-9.

36. Peña-Casanova J, Meza M, Bertrán-Serra I, Manero R, Espel G. Versión abreviada del Tes. Barcelona(III) Validez de criterio con el ADAS-Cog. Neurología 1997; 12: 29-31.

37. Perrine K, Kiolbasa T. Cognitive deficits in epilepsy and contribution to psychopathology. Neurology 1991; 53(Suppl. 2): S39-S48.

38. Trimble MR. Cognitive hazards of seizure disorders. Epilepsia 1988; 29(Suppl. 1): S19-S24.

39. Carl GF, Smith DB. Interaction of phenytoin and folate in the rat. Epilepsia 1983; 24: 494-501.

40. Rivey MP, Schottelius DD, Berg MJ. Phenytoin-folic acid: a review. Drug Intell Clin Pharm 1984; 18: 292-301.

41. Lesser RP, Luder H, Wyllie E, Dinner DS, Morris H. Mental deterioration in epilepsy. Epilepsia 1986; 27: S105-S123.

42. Smith DB, Craft BR, Collin J, Mattson RH. Behavioral characteristic of epilepsy patients compared with normal controls. Epilepsia 1986; 27: 760-8.

43. Mayeux R, Bradt J, Rosen J, Benson DF. Interictal memory and language impairment in temporal lobe epilepsy. Neurology 1980; 30: 120-5.

44. Herman BP, Wyaler AR, Richey ET, Rea JM. Memory function and verbal learning ability in patients with complex partial seizures of temporal lobe origin. Epilepsia 1987; 28: 547-54.

45. Barr WB, Consortium BE. The right temporal lobe and memory: a critical reexamination. J Int Neuropsychol Soc 1995; 1: 139-49.

46. Dodrill CB. Correlates of generalized tonic-clonic seizure with intellectual, neuropsychological emotional and social function in patients with epilepsy. Epilepsia 1986; 27: 399-411.

47. Butlin AT, Danta G, Cook ML. Anticonvulsivants, folic acid and memory dysfunction in epileptic. Clin Exp Neurol 1984; 20: 57-62.

48. Hassing L, Wahlin A, Winblad B, Backman L. Further evidence on the effects of vitamin B12, and folate levels on episodic memory functioning: a population-based study of healthy very old adults. Biol Psychiatry 1999; 45: 1472-80.

49. Nilsson K, Gustafson L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16: 609-14.

50. Calandre EP, Jorde F, Rodriguez E. Serum folate concentrations in epileptic patients treated with carbamazepine and valproate. Epilepsia 1991; 32: S1: S75.

51. Meador K, Loring D. Cognitive effect of antiepileptic drugs. En Devinky O, Theodore W (Eds.). Epilepsy and behavior. New York: Wiley-Liss; 1991, pp. 151-70.